- Home
- DTI vs UNCY Comparison
DTI vs UNCY Comparison
Compare DTI & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTI
- UNCY
- Stock Information
- Founded
- DTI 1984
- UNCY 2016
- Country
- DTI United States
- UNCY United States
- Employees
- DTI 447
- UNCY N/A
- Industry
- DTI Metal Fabrications
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- DTI Industrials
- UNCY Health Care
- Exchange
- DTI Nasdaq
- UNCY Nasdaq
- Market Cap
- DTI 68.0M
- UNCY 71.8M
- IPO Year
- DTI N/A
- UNCY 2021
- Fundamental
- Price
- DTI $1.88
- UNCY $0.60
- Analyst Decision
- DTI Strong Buy
- UNCY Strong Buy
- Analyst Count
- DTI 1
- UNCY 2
- Target Price
- DTI $5.50
- UNCY $5.25
- AVG Volume (30 Days)
- DTI 114.2K
- UNCY 1.2M
- Earning Date
- DTI 05-08-2025
- UNCY 05-12-2025
- Dividend Yield
- DTI N/A
- UNCY N/A
- EPS Growth
- DTI N/A
- UNCY N/A
- EPS
- DTI 0.09
- UNCY N/A
- Revenue
- DTI $154,446,000.00
- UNCY N/A
- Revenue This Year
- DTI $12.21
- UNCY N/A
- Revenue Next Year
- DTI $6.26
- UNCY $1,677.16
- P/E Ratio
- DTI $20.89
- UNCY N/A
- Revenue Growth
- DTI 1.59
- UNCY N/A
- 52 Week Low
- DTI $1.43
- UNCY $0.20
- 52 Week High
- DTI $6.36
- UNCY $1.29
- Technical
- Relative Strength Index (RSI)
- DTI 38.67
- UNCY 54.18
- Support Level
- DTI $1.75
- UNCY $0.45
- Resistance Level
- DTI $2.03
- UNCY $0.63
- Average True Range (ATR)
- DTI 0.29
- UNCY 0.06
- MACD
- DTI 0.00
- UNCY 0.01
- Stochastic Oscillator
- DTI 38.14
- UNCY 78.95
About DTI Drilling Tools International Corporation
Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.